跳至主要内容
临床试验/NCT00236171
NCT00236171已完成不适用

Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

Technische Universität Dresden2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2004年9月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
sum score of psoriasis plaque tests on day 11

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test

详细描述

daily psoriasis plaque tests for two weeks and optical coherence tomography (OCT) and 20-MHz-ultrasound on day 0 and day 11, 10 days post end of treatment and 20 days post end of treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 Years
  • Negative urine pregnancy test
  • Written informed consent
  • Good compliance

排除标准

  • Patients less than 18 years
  • Pregnant patients
  • Patients with renal insufficiency, liver diseases
  • Patients who received systemic antipsoriatic treatment or UV treatment less than 4 weeks prior to study
  • Patients who used topical antipsoriatics within two weeks prior to study
  • Immunosuppressed Patients

结局指标

主要结局

sum score of psoriasis plaque tests on day 11

次要结局

  • 20-MHz-ultrasound and OCT on day 11

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验